NICOLE WHITE: Open Payments
NPI 1376153262 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 27 payments from 10 companies in 2025. Trend: 2023 $53 · 2024 $365 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $191 |
| Optinose US, Inc. | 5 | $160 |
| AstraZeneca Pharmaceuticals LP | 2 | $133 |
| GENZYME CORPORATION | 3 | $119 |
| Inspire Medical Systems, Inc. | 3 | $117 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $57 |
| Genentech USA, Inc. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Amgen Inc. | 1 | $25 |
Products named: NUCALA, Xhance, DUPIXENT, TEZSPIRE, INSPIRE, NEFFY, Xolair, Rhapsido.
Industry payments across VA — which companies pay providers there.
